Brain Tumor Treatments: Oklahoma

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

[Click HERE to print this page!]

Search Term: Oklahoma
Please scroll down to see the matching trials.

  (0.8912) Brain Tumor Treatments: Oklahoma
  (0.7742) Untitled Document
  (0.7742) Brainstem Glioma
  (0.7742) Brain Tumor Activism
  (0.7742) Letter Writing Wizard
  (0.7742) Brain Tumor Activism
  (0.7742) Medulloblastoma

Sorry - There were no pages found that contain that search phrase.


	Treatment	Location	Last Updated

Details	Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma	Tulsa, OK USA	04/11/2008

Details	Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor	Oklahoma City, OK USA	08/18/2007

Details	A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas	Tulsa, OK USA	05/01/2007

Details	Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma	Oklahoma City, OK USA	05/30/2006

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	Tulsa, OK USA	11/27/2005

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	Oklahoma City, OK USA	11/27/2005

Details	Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors	Oklahoma City, OK USA	11/26/2005

Details	A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy	Tulsa, OK USA	11/06/2005